AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

France Tumor Markers Sales Segment Forecasts for over 40 Tests - 2019 - ResearchAndMarkets.com

January 9, 2020 GMT

DUBLIN--(BUSINESS WIRE)--Jan 9, 2020--

The “France Tumor Markers Sales Segment Forecasts for over 40 Tests: Supplier Shares and Strategies, Volume and Sales Segment Forecasts, Emerging Tests, Technologies and Opportunities” report has been added to ResearchAndMarkets.com’s offering.

The author’s new report is a study of the major business opportunities emerging in the French cancer diagnostics market during the next five years. The report examines trends in the French cancer diagnostics markets, reviews current and emerging assays; analyzes potential applications of new diagnostic technologies; forecasts sales of major tumor markers by market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers.

Rationale

The cancer diagnostics market is on the verge of explosion, as the researchers approach major technological breakthroughs in tumor diagnosis and therapy, discover new specific antigens, and unlock the mystery of the genetic basis of the disease. During the next five years, the worldwide cancer diagnostics market is promising to be an exciting, dynamic and rapidly expanding field. Anticipated technological breakthroughs will create numerous opportunities for determining genetic predisposition, detecting specific tumors, and monitoring biological response to cancer therapy. The rise in geriatric population will further compound the growing demand for malignancy assays and the rapid market expansion worldwide.

France Market Overview

Business Opportunities and Strategic Recommendations

Over 200 Current and Emerging Cancer Diagnostic Test

Supplier Shares, Sales and Volume Forecasts

Instrumentation Review

Technology Assessment

chromosome analysis, IT, artificial intelligence, flow cytometry, and other technologies and their potential applications for cancer diagnostic testing.

Competitive Strategies

The companies analyzed in the report include:

For more information about this report visit https://www.researchandmarkets.com/r/km9m72

View source version on businesswire.com:https://www.businesswire.com/news/home/20200109005377/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

KEYWORD: FRANCE EUROPE

INDUSTRY KEYWORD: HEALTH ONCOLOGY MEDICAL DEVICES

SOURCE: Research and Markets

Copyright Business Wire 2020.

PUB: 01/09/2020 06:16 AM/DISC: 01/09/2020 06:16 AM

http://www.businesswire.com/news/home/20200109005377/en